SUPEMTEK
SUPEMTEK
Dormant
DIN Number
02510936
Drug Class
Human
Market Date
Oct 3, 2022
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02510936
AIG Number0462721001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H1N1)Active
Strength: 45 MCG / 0.5 ML
Monograph: RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H1N1)
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H3N2)Active
Strength: 45 MCG / 0.5 ML
Monograph: RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H3N2)
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (VICTORIA)Active
Strength: 45 MCG / 0.5 ML
Monograph: RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (VICTORIA)
RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (YAMAGATA)Active
Strength: 45 MCG / 0.5 ML
Monograph: RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (YAMAGATA)